TOFACITINIB FOR THE TREATMENT OF ULCERATIVE COLITIS: UP TO 6.8 YEARS OF SAFETY DATA FROM GLOBAL CLINICAL TRIALS

William Sandborn  ¹     Julian Panés  ²     Geert R. D'Haens  ³     Bruce E. Sands  ⁴     Remo Panaccione  ⁵     Siew Cheng Ng  ⁶     Thomas V Jones  ⁷     Nervin Lawendy  ⁷     nicole kulisek  ⁷     Rajiv Mundayat  ⁸     Chinyu Su  ^8    
1 University of California San Diego, La Jolla, United States
² Hospital Clínic de Barcelona, IDIBAPS, CIBERehd, Barcelona, Spain
³ Academic Medical Center, Amsterdam, Netherlands
⁴ Icahn School of Medicine at Mount Sinai, New York, United States
⁵ University of Calgary, Calgary, Canada
⁶ Center for Gut Microbiota Research, Department of Medicine and Therapeutics, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, Hong Kong, China (SAR)
⁷ Pfizer Inc, Collegeville, United States
⁸ Pfizer Inc, New York, United States

Session
IBD (Posters)

Conference
UEG Week Virtual 2020

Citation
United European Gastroenterology Journal 2020; 8 (Supplement 1)